Arcturus Therapeutics Holdings Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
169.49 |
80.99 |
107.86 |
214.14 |
505.30 |
749.54 |
Przychód Δ r/r |
0.00% |
-52.22% |
33.18% |
98.54% |
135.97% |
48.34% |
Przychód (min) |
152.63 |
60.24 |
14.60 |
212.56 |
276.52 |
410.18 |
Przychód (max) |
200.07 |
136.83 |
279.46 |
215.72 |
934.01 |
1,385.47 |
EBITDA (średnia) |
-89.69 |
-42.86 |
-57.08 |
-113.32 |
-267.39 |
-396.64 |
EBIT (średnia) |
-91.45 |
-43.70 |
-58.19 |
-115.54 |
-272.63 |
-404.40 |
EBIT % |
-53.95% |
-53.95% |
-53.95% |
-53.95% |
-53.95% |
-53.95% |
Zysk netto (średni) |
-68.20 |
-89.03 |
-77.44 |
36.74 |
118.59 |
237.74 |
Zysk netto % |
-40.24% |
-109.93% |
-71.80% |
17.16% |
23.47% |
31.72% |
EPS (średnia) |
-2.43 |
-3.30 |
-2.78 |
-0.31 |
4.39 |
8.80 |
Liczba analityków (Przychody) |
8 |
7 |
11 |
8 |
6 |
7 |
Liczba analityków (EPS) |
8 |
7 |
9 |
6 |
3 |
4 |
symbol |
ARCT |
ARCT |
ARCT |
ARCT |
ARCT |
ARCT |